Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Screening potential therapies: lessons learned from new paradigms used in Parkinson disease.
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials. 2022 Oct 06; 23(1):855.
View in:
PubMed
subject areas
Antiparkinson Agents
Brain-Derived Neurotrophic Factor
Clinical Trials, Phase III as Topic
C-Reactive Protein
Dopamine Plasma Membrane Transport Proteins
Exercise
Exercise Therapy
Humans
Multicenter Studies as Topic
Parkinson Disease
Quality of Life
Randomized Controlled Trials as Topic
Treatment Outcome
authors with profiles
Barbara C. Tilley